Discover 2,121 paid clinical trials in Toronto, Ontario. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,121
Ex-vivo Delivery of Rituximab to Prevent PTLD in EBV Mismatch Lung Transplant Recipients: A Pilot Trial
for
Epstein-Barr Virus Infections,
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: All
Age: 18+
Code: NCT04507477
Phase 1, Phase 2, Recruiting
POEM for Spastic Esophageal Disorders
for
Esophageal Achalasia
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: All
Age: 18 - 70+
Code: NCT02425033
Recruiting
Using Rectal Hydrogel Spacer for Salvage SABR in Prostate Cancer
for
Prostate Cancer
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre
Sex: Male
Age: 18+
Code: NCT05597852
Recruiting
The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression
for
Major Depressive Disorder, Anxiety
Location: Toronto, Kingston
Sponsor: NuBiyota
Sex: All
Age: 18 - 45
Code: NCT04602715
Phase 2, Recruiting
Chemoimmunotherapy Followed by Surgery for Oligometastatic Esophagogastric Cancer: (TORO Protocol)
Persistent Atrial Fibrillation Ablation and Correlation to Quality of Life
for
Atrial Fibrillation
Location: Newmarket
Sponsor: Newmarket Electrophysiology Research Group Inc
Sex: All
Age: 18+
Code: NCT04290559
Recruiting
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
for
Atrial Fibrillation (AF)
Location: Toronto, Markham, Saint Catharines, Hamilton, Cambridge,
Sponsor: Anthos Therapeutics, Inc.
Sex: All
Age: 65+
Code: NCT05712200
Phase 3, Recruiting
Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Caregivers of Patients With Advanced Cancer
for
Caregiver Distress
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: All
Age: 18+
Code: NCT07048743
Phase 2, Recruiting
L-dopa Versus Dopamine Agonists After Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease
for
Parkinson's Disease
Location: Toronto
Sponsor: University of Toronto
Sex: All
Age: 0+
Code: NCT02347059
Phase 2, Recruiting
A First-in-Human Safety and Efficacy Study of ALN-CFB, a Small Interfering RNA (siRNA) Targeting Complement Factor B, in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria With Persistent Anemia on a C5 Inhibitor